Highbridge Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-60,746
| Closed | -$128K | – | 1392 |
|
|
2017
Q3 | $128K | Buy |
60,746
+15,426
| +34% | +$32.5K | ﹤0.01% | 738 |
|
|
2017
Q2 | $132K | Buy |
+45,320
| New | +$132K | ﹤0.01% | 777 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1363 |
|
|
2015
Q3 | – | Sell |
-6,247
| Closed | -$309K | – | 1339 |
|
|
2015
Q2 | $309K | Buy |
6,247
+618
| +11% | +$30.6K | ﹤0.01% | 684 |
|
|
2015
Q1 | $441K | Buy |
+5,629
| New | +$441K | 0.01% | 597 |
|
|
2014
Q4 | – | Sell |
-48,963
| Closed | -$2.09M | – | 1232 |
|
|
2014
Q3 | $2.09M | Buy |
+48,963
| New | +$2.09M | 0.03% | 399 |
|
|
2013
Q4 | – | Sell |
-2,954
| Closed | -$181K | – | 1226 |
|
|
2013
Q3 | $181K | Buy |
+2,954
| New | +$181K | ﹤0.01% | 841 |
|